![Erin Boyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Boyer
Responsable des Ressources Humaines chez UNIQURE N.V.
Postes actifs de Erin Boyer
Sociétés | Poste | Début | Fin |
---|---|---|---|
UNIQURE N.V. | Responsable des Ressources Humaines | 01/04/2022 | - |
Historique de carrière de Erin Boyer
Anciens postes connus de Erin Boyer
Sociétés | Poste | Début | Fin |
---|---|---|---|
Obsidian Therapeutics, Inc.
![]() Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Responsable des Ressources Humaines | - | - |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
EPIZYME, INC. | Responsable des Ressources Humaines | 01/11/2020 | - |
Formation de Erin Boyer
Macalester College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Pays-Bas | 2 |
Opérationnelle
Human Resources Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
UNIQURE N.V. | Health Technology |
Entreprise privées | 2 |
---|---|
Epizyme, Inc.
![]() Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Obsidian Therapeutics, Inc.
![]() Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Erin Boyer
- Expérience